P-glycoprotein

You have access
HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and in vivo antitumor efficacy of paclitaxel in an orthotopic brain tumor model
Wu Zeng, Betty Yuen Kwan Law, Vincent Kam Wai Wong, Denise So Bik Chan, Simon Wing Fai Mok, Joyce Jia Ying Gao, Rebecca Ka Yan Ho, Xu Liang, Jia Hao Li, Ming Tsung Lee, Weng Li Yoon, Michael P Smolinski, Johnson Yiu Nam Lau, Christopher Wai Kei Lam and Manson Fok

Cancer Biology & Medicine November 2020, 17 (4) 986-1001; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0128
You have access
Identification of the Interaction between P-Glycoprotein and Anxa2 in Multidrug-resistant Human Breast Cancer Cells
Hai-chang Zhang, Fei Zhang, Bing Wu, Jing-hua Han, Wei Ji, Yan Zhou and Rui-fang Niu

Cancer Biology & Medicine June 2012, 9 (2) 99-104; DOI: https://doi.org/10.3969/j.issn.2095-3941.2012.02.003
You have access
Ability of a Specific ERK Signal-Pathway Inhibitor to Reverse P-Glycoprotein-Mediated Vincristine Resistance in Colon Cancer Cell Lines
Feng Jin, Hua Fan, Bo Chen, Ping Lu, Fan Yao, Huimian Xu and Shubao Wang

Chinese Journal of Clinical Oncology August 2004, 1 (4) 295-300;

Main menu